Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cross-Border Impact Ventures is a Toronto-based impact venture capital firm focused on health technology investments. The firm targets companies that improve health technologies for women, children, and adolescents, with a portfolio of 8 companies. Their investment strategy emphasizes both social impact and financial returns, particularly in low- and middle-income countries.
This firm invests in medical devices, diagnostics, therapeutics, and digital health innovations. They specifically target opportunities that address gender health inequalities, aiming for investments that yield positive social impact alongside financial returns. Their investment stages include Seed, Series A, and Series B.
Notable portfolio companies include Pendulum, an AI-driven health infrastructure software company; Raydiant Oximetry, which develops non-invasive fetal monitoring devices; Sonio, an AI-enabled fetal ultrasound software company; and Daye, a Femtech firm focused on gynecological health.
The firm focuses on health technology companies that address gender health inequalities, particularly in sectors like maternal and child health.
They invest in Seed, Series A, and Series B stages, targeting early to growth-stage companies.
The firm primarily invests in North America, Europe, and Latin America, with a focus on low- and middle-income countries.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.